Bausch Health Companies Inc. (NYSE:BHC) Shares Acquired by Mackenzie Financial Corp

Mackenzie Financial Corp increased its holdings in Bausch Health Companies Inc. (NYSE:BHC) by 26.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,562,694 shares of the company’s stock after buying an additional 331,462 shares during the quarter. Mackenzie Financial Corp owned about 0.43% of Bausch Health Companies worth $12,543,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the business. Lazard Asset Management LLC acquired a new position in shares of Bausch Health Companies during the second quarter valued at $49,000. FMR LLC increased its stake in Bausch Health Companies by 58.3% during the 2nd quarter. FMR LLC now owns 10,057 shares of the company’s stock valued at $84,000 after buying an additional 3,703 shares during the period. Ausdal Financial Partners Inc. acquired a new position in Bausch Health Companies during the 3rd quarter valued at about $86,000. Jump Financial LLC bought a new stake in shares of Bausch Health Companies during the 3rd quarter worth about $92,000. Finally, NewEdge Advisors LLC acquired a new stake in shares of Bausch Health Companies in the 2nd quarter worth approximately $95,000. 78.65% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on BHC shares. Royal Bank of Canada reiterated a “sector perform” rating and set a $12.00 price objective on shares of Bausch Health Companies in a research note on Friday, April 12th. StockNews.com raised Bausch Health Companies from a “hold” rating to a “buy” rating in a report on Wednesday, February 7th. Finally, Jefferies Financial Group cut their price target on shares of Bausch Health Companies from $16.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, February 20th.

Bausch Health Companies Stock Performance

NYSE BHC opened at $8.69 on Friday. The stock has a market capitalization of $3.18 billion, a P/E ratio of -5.36 and a beta of 0.85. The business’s fifty day moving average is $9.29 and its two-hundred day moving average is $8.15. Bausch Health Companies Inc. has a 1 year low of $5.57 and a 1 year high of $11.46.

Bausch Health Companies (NYSE:BHC) last announced its earnings results on Thursday, February 22nd. The company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.01 by $0.14. Bausch Health Companies had a positive return on equity of 5,147.48% and a negative net margin of 6.76%. The company had revenue of $2.41 billion for the quarter, compared to analyst estimates of $2.29 billion. During the same period in the previous year, the firm earned $1.02 earnings per share. Bausch Health Companies’s revenue for the quarter was up 9.8% compared to the same quarter last year. On average, research analysts forecast that Bausch Health Companies Inc. will post 3.95 earnings per share for the current year.

Bausch Health Companies Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.